Research programme: autologous cultured GI tissue cells - RegenMedTX

Drug Profile

Research programme: autologous cultured GI tissue cells - RegenMedTX

Alternative Names: Neo-GI Augment; Neo-oesophageal implant - RegenMedTX

Latest Information Update: 04 Nov 2017

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Tengion
  • Developer RegenMedTX
  • Class Cell therapies
  • Mechanism of Action Cell replacements
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • No development reported Gastrointestinal disorders

Most Recent Events

  • 04 Nov 2017 No recent reports of development identified for preclinical development in Gastrointestinal-disorders in USA (Parenteral, Implant)
  • 10 Jul 2013 Preclinical trials in Gastrointestinal disorders in USA (Parenteral)
  • 20 Sep 2010 Early research in Gastrointestinal disorders in USA (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top